Clinical validation of an analytical procedure for in vivo PET range verification in proton therapy

IEEE Nuclear Science Symposium Conference Record

Volumn , Issue , 2009, Pages 4167-4171

  Attanasi, Francesca ^a   Knopf, Antje ^b   Parodi, Katia ^d   Bortfeld, Thomas ^c   Paganetti, Harald ^c   Rosso, Valeria ^a   Del Guerra, Alberto ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Positron emission tomography; Proton therapy; Range monitoring

Indexed keywords

ACTIVITY DISTRIBUTION; ANALYTICAL MODEL; ANALYTICAL PROCEDURE; CONVENTIONAL RADIATION THERAPY; DOSE DELIVERY; DOSE DISTRIBUTIONS; FLEXIBLE FRAMEWORK; GEOMETRIC ACCURACY; HIGH DOSE; HIGH QUALITY; IN-VIVO; INITIAL TREATMENT; INTEGRAL DOSE; LINEAR ENERGY TRANSFER; MONTE CARLO; PATIENT DOSE; PET IMAGES; PLANNED TREATMENTS; PLANNING CT; POSITRON EMITTERS; POTENTIAL BENEFITS; PROTON BRAGG PEAK; PROTON THERAPY; RADIATION ONCOLOGY; RADIATION THERAPY TREATMENT; RANGE MONITORING; SIDE EFFECT; SUBSTITUTION METHOD; TREATMENT MODALITY; TREATMENT PLANNING SYSTEMS; UNCERTAINTY SOURCES;

COMPUTERIZED TOMOGRAPHY; ELECTRONS; ENERGY TRANSFER; IRRADIATION; ISOTOPES; NUCLEAR PHYSICS; ONCOLOGY; POSITRONS; PROTON BEAMS; PROTONS; RADIATION; RADIOTHERAPY;

POSITRON EMISSION TOMOGRAPHY;

EID: 77951188765     PISSN: 10957863     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1109/NSSMIC.2009.5402292     Document Type: Conference Paper

References (15)

1. 15O activation in proton radiation therapy, Nuc. Instr. Meth., 1975, 125(3), pp. 333-338.
2. Bennett G. W. et al, Visualization and transport of positron emission from proton activation in vivo, Science, 1978, 200(4346), pp. 1151-1153.
3. Parodi K. et al, Patient study of in vivo verification of beam delivery and range, using positron emission tomography and computed tomography imaging after proton therapy, J. Radiat. Oncol. Biol. Phys., 2007, 68(3), pp. 920-934.
4. Knopf A. et al, Systematic analysis of biological and physical limitations of proton beam range verification with offline PET/CT scans, Phys. Med. Biol., 2009, 54, pp. 4477-4495.
5. Parodi K. et al, Clinical CT-based calculations of dose and positron emitter distributions in proton therapy using the FLUKA Monte Carlo code, Phys. Med. Biol., 2007, 52(12), pp. 3369-3387.
6. Parodi K. and Bortfeld, T., A filtering approach based on Gaussian-powerlaw convolutions for local PET verification of proton radiotherapy, Phys. Med. Biol., 2006, 51(8), pp. 1991-2009.
7. Gradshteyn IS, Ryzhik IM. Table of integrals, series and products. San Diego: Academic; 1980.
8. Bortfeld T., An Analytical Approximation of the Bragg Curve for Therapeutic Proton Beams, Phys. Med. Biol., 1996, 41, 1331-1339.
9. Attanasi F. et al, Experimental validation of the filtering approach for dose monitoring in proton therapy at low energy, Phys. Med., 2008, 24(2), pp. 102-106.
10. Vecchio S. et al, A PET Prototype for In-Beam Monitoring of Proton Therapy, IEEE Transactions on Nuclear Science, 2009, 56(1), pp. 51-56.
11. +-activity, Phys. Med. Biol., 2009, 54, N29-N35.
12. Bortfeld T., An analytical approximation of the Bragg curve for therapeutic proton beams, Med. Phys., 1997, 24, pp. 2024-2033.
13. Schneider W. et al, Correlation between CT numbers and tissue parameters needed for Monte Carlo simulations of clinical dose distributions, Phys. Med. Biol., 2000, 45, pp. 459-478.
14. Parodi K. et al, PET/CT imaging for treatment verification after proton therapy: a study with plastic phantoms and metallic implants, Med. Phys., 2007a, 34, pp. 419-435.
15. Knopf A. et al, Quantitative assessment of the physical potential of proton beam range verification with PET/CT, Phys. Med. Biol., 2008, 53, pp. 4137-4151.